Form D · Pharmaceuticals
LAM PHARMACEUTICAL CORP
Toronto, A6 · CIK 0001071272
Offering snapshot reported Oct 24, 2013 · SEC filing
- Reported sold
- $172K Offering amount: $1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $17K Reported outside-investor minimum
- First sale
- Aug 1, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 24, 2013 | Initial | $172,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04, 04.1, 04.2, 04.3
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $15K
- Finders' fees
- $5K
- Form D file number
- 021-205333
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| DLM | None |
Source: Form D, filed Oct 24, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Adams | Executive |
| Pepe Carla | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
425 University Av. Suite 601
Toronto, A6, M5G1T6
Toronto, A6, M5G1T6